NO20061951L - Fremgangsmater for fremstillingen av benzoksazol-sulfonamid-forbindelser og intermediater derav - Google Patents

Fremgangsmater for fremstillingen av benzoksazol-sulfonamid-forbindelser og intermediater derav

Info

Publication number
NO20061951L
NO20061951L NO20061951A NO20061951A NO20061951L NO 20061951 L NO20061951 L NO 20061951L NO 20061951 A NO20061951 A NO 20061951A NO 20061951 A NO20061951 A NO 20061951A NO 20061951 L NO20061951 L NO 20061951L
Authority
NO
Norway
Prior art keywords
benzoxazole
preparation
sulfonamide compounds
intermediates
processes
Prior art date
Application number
NO20061951A
Other languages
English (en)
Norwegian (no)
Inventor
Herman Augustinus De Kock
Walter Ferdinand Mari Filliers
Wim Albert Alex Aelterman
Original Assignee
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd
Publication of NO20061951L publication Critical patent/NO20061951L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20061951A 2003-09-30 2006-05-02 Fremgangsmater for fremstillingen av benzoksazol-sulfonamid-forbindelser og intermediater derav NO20061951L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03103630 2003-09-30
US50799603P 2003-10-02 2003-10-02
PCT/EP2004/052382 WO2005030739A1 (en) 2003-09-30 2004-09-30 Methods for the preparation of benzoxazole sulfonamide compounds and intermediates thereof

Publications (1)

Publication Number Publication Date
NO20061951L true NO20061951L (no) 2006-05-02

Family

ID=34395298

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20061951A NO20061951L (no) 2003-09-30 2006-05-02 Fremgangsmater for fremstillingen av benzoksazol-sulfonamid-forbindelser og intermediater derav

Country Status (24)

Country Link
US (1) US20070123574A1 (pt)
EP (1) EP1670773B1 (pt)
JP (1) JP4919802B2 (pt)
KR (1) KR101090102B1 (pt)
CN (1) CN1860107B (pt)
AP (1) AP1985A (pt)
AT (1) ATE353323T1 (pt)
AU (1) AU2004276017B2 (pt)
BR (1) BRPI0414916A (pt)
CA (1) CA2537877C (pt)
DE (1) DE602004004674T2 (pt)
DK (1) DK1670773T3 (pt)
EA (1) EA011891B1 (pt)
ES (1) ES2281828T3 (pt)
IL (1) IL173891A0 (pt)
IN (1) IN2012DN02301A (pt)
MX (1) MXPA06003575A (pt)
NO (1) NO20061951L (pt)
NZ (1) NZ546279A (pt)
PL (1) PL1670773T3 (pt)
PT (1) PT1670773E (pt)
SI (1) SI1670773T1 (pt)
WO (1) WO2005030739A1 (pt)
ZA (1) ZA200602603B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR053845A1 (es) * 2005-04-15 2007-05-23 Tibotec Pharm Ltd 5-tiazolilmetil[(1s,2r)-3-[[(2-amino-6-benzoxazolil)sulfonil)](2-metilpropil)amino]-2-hidroxi-1-(fenilmetil)propil]carbamato como mejorador de farmacos metabolizados por el citocromo p450
WO2011044134A1 (en) * 2009-10-05 2011-04-14 Albany Molecular Research, Inc. Epiminocycloalkyl(b)indole derivatives as serotonin sub-type 6 (5-ht6) modulators and uses thereof
CA2823955A1 (en) 2011-01-19 2012-07-26 Albany Molecular Research, Inc. Benzofuro[3,2-c] pyridines and related analogs as serotonin sub-type 6 (5-ht6) modulators for the treatment of obesity, metabolic syndrome, cognition and schizophrenia
WO2014194519A1 (en) 2013-06-07 2014-12-11 Merck Sharp & Dohme Corp. Imidazole derivatives and methods of use thereof for improving pharmacokinetics of drug

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968942A (en) * 1992-08-25 1999-10-19 G. D. Searle & Co. α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
DE69625183T2 (de) * 1995-03-10 2003-10-09 Searle & Co Heterocyclocarbonyl-aminosäure-hydroxyethylamino-sulfonamid inhibitoren retroviraler proteasen
EP0861249A1 (en) * 1995-11-15 1998-09-02 G.D. Searle & Co. Substituted sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
CA2372352A1 (en) * 2000-04-07 2001-10-18 Hyun-Gyu Park Sulfonamide derivative as a matrix metalloproteinase inhibitor
US6455738B1 (en) * 2000-07-13 2002-09-24 Rhodia Chimie Process for the sulfonation of an aromatic compound
MXPA03007236A (es) * 2001-02-14 2003-12-04 Tibotec Pharm Ltd 2-(amino sustituido)-benzotiazol sulfonamidas inhibidoras de proteasa de vih de amplio espectro.
AR035970A1 (es) * 2001-05-11 2004-07-28 Tibotec Pharm Ltd 2-amino-benzoxazol sulfonamidas inhibidoras de amplio espectro de la hiv proteasa, composicion farmaceutica, metodo "in vitro" para inhibir la replicacion retroviral, y utilizacion de estos compuestos en la manufactura de medicamentos
AR037797A1 (es) * 2001-12-12 2004-12-01 Tibotec Pharm Ltd Combinacion de inhibidores de proteasa dependientes del citocromo p450
MY142238A (en) * 2002-03-12 2010-11-15 Tibotec Pharm Ltd Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors

Also Published As

Publication number Publication date
JP4919802B2 (ja) 2012-04-18
ATE353323T1 (de) 2007-02-15
IL173891A0 (en) 2006-07-05
AU2004276017A1 (en) 2005-04-07
DK1670773T3 (da) 2007-05-29
JP2007507468A (ja) 2007-03-29
KR101090102B1 (ko) 2011-12-07
CN1860107B (zh) 2013-08-21
ES2281828T3 (es) 2007-10-01
KR20060092224A (ko) 2006-08-22
AU2004276017B2 (en) 2010-08-19
EA200600699A1 (ru) 2006-08-25
US20070123574A1 (en) 2007-05-31
BRPI0414916A (pt) 2006-11-07
NZ546279A (en) 2008-09-26
IN2012DN02301A (pt) 2015-08-14
AP2006003603A0 (en) 2006-04-30
PL1670773T3 (pl) 2007-06-29
DE602004004674T2 (de) 2007-11-22
ZA200602603B (en) 2008-05-28
WO2005030739A1 (en) 2005-04-07
EP1670773B1 (en) 2007-02-07
CN1860107A (zh) 2006-11-08
EA011891B1 (ru) 2009-06-30
CA2537877C (en) 2015-03-17
CA2537877A1 (en) 2005-04-07
EP1670773A1 (en) 2006-06-21
PT1670773E (pt) 2007-05-31
SI1670773T1 (sl) 2007-06-30
MXPA06003575A (es) 2006-06-05
AP1985A (en) 2009-03-30
DE602004004674D1 (de) 2007-03-22

Similar Documents

Publication Publication Date Title
NO20050199L (no) Azadisyklo-oktan og nonanderivater med DDP-IV-inhiberende aktivitet
ES2282685T3 (es) Derivados de hidroxietilamina para el tratamiento de la enfermedad de alzheimer.
NO20014484D0 (no) Nye forbindelser og sammensetninger som proteaseinhibitorer
DK1789398T3 (da) 2-amino-quinazolin derivater anvendelige som inhibitorer af B-sekretase (BACE)
NO20012921L (no) Fenylglycin-derivater
NO20063401L (no) Fremgangsmate for fremstillingen av (3R,3AS,6AR)-heksahydrofuro [2,3-B]furan-3-yl (1S,2R)-3-[[(4-aminofenyl)sulfonyl](isobutyl) amino]-1-benzyl-2-hydroksypropylkarbamat
DK1421074T3 (da) Nye forbindelser
NI200700056A (es) Nuevos derivados de sulfamidas de heteroaril benzo-fundido útiles como agentes anticonvulsivos
NO20081013L (no) 7-substituerte aza-indazoler, sammensetninger inneholdende disse, produksjonsmetode og anvendelse derav
HRP20050352A2 (en) Piperazinyl and diazapanyl benzamides and benzthioamides
EA200401157A1 (ru) N-аминоацетилпирролидин-2-карбонитрилы и их применение в качестве ингибиторов ddp-iv
UY27774A1 (es) Inhibidores de metaloproteinas de triaril-oxi-aril-espiropirimidina-2,4,6-triona
ATE451370T1 (de) Verbesserte verfahren zur herstellung von n-(ä1,2,4ütriazolopyrimidin-2-yl)arylsulfonamid n
NO20005261L (no) Nye heterocyklisk substituerte amider med cystein-protease- inhiberende virkning
SE0403171D0 (sv) New compounds
NO20061951L (no) Fremgangsmater for fremstillingen av benzoksazol-sulfonamid-forbindelser og intermediater derav
NO20034667L (no) Arylsulfonamider som antivirale midler
DK1583756T3 (da) Thiophencarboxamider som inhibitorer af enzymet IKK-2
NO20080661L (no) Nye cystein-protease-inhibitorer og deres terapeutiske anvendelser
DK1819704T3 (da) Pyrrolopyridin-2-carboxylsyre-amid-derivat anvendelig som inhibitor af glycogenphosphorylase
NO20060258L (no) Nematicidale tiazolin-inneholdende fluorobutener
AR039937A1 (es) Derivados de azetidina como inhibidores de tripsina proteasas
NO20044881L (no) Acyl-3-karboksyfenylureaderivater, fremstillingsfremgangsmate og anvendelse derav
MEP48608A (en) Piperazine containing phosphonic acid compounds as inhibitors of serine proteases
NO20054442L (no) Pyrrolidinderivater som oksytocinantagonister

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application